Short-term physical training in bronchial asthma. 1983

A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen

The effect of two types of physical training on patients with perennial asthma were compared in a blind, controlled, randomized study. Eleven of 27 adults with asthma performed a physical training programme which did not change their oxygen consumption (control group). The remaining 16 asthmatics performed a physical training programme which improved their maximal oxygen consumption (training group). Both of the training programmes were performed for 1 hour, twice a week during a period of 2 months. No complications were reported during the performance of the training programmes. The doses of all medicines apart from beta 2-agonist aerosol were unchanged during the training period. The patients inhaled beta 2-agonist aerosol if their peak expiratory flow (PEF) was less than 60% of their maximal PEF. The training group decreased their use of aerosol from an average of 4.94 puffs per day to 3.41 puffs per day (P less than 0.05). The control group did not change their use of beta 2-agonist aerosol significantly. It is concluded that physical exercise which improves the maximal oxygen consumption decreases the use of beta 2-agonist spray and that heavy exercise is well tolerated by asthmatics.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010101 Oxygen Consumption The rate at which oxygen is used by a tissue; microliters of oxygen STPD used per milligram of tissue per hour; the rate at which oxygen enters the blood from alveolar gas, equal in the steady state to the consumption of oxygen by tissue metabolism throughout the body. (Stedman, 25th ed, p346) Consumption, Oxygen,Consumptions, Oxygen,Oxygen Consumptions
D010806 Physical Education and Training Instructional programs in the care and development of the body, often in schools. The concept does not include prescribed exercises, which is EXERCISE THERAPY. Education, Physical,Physical Education,Physical Education, Training
D011897 Random Allocation A process involving chance used in therapeutic trials or other research endeavor for allocating experimental subjects, human or animal, between treatment and control groups, or among treatment groups. It may also apply to experiments on inanimate objects. Randomization,Allocation, Random
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000318 Adrenergic beta-Agonists Drugs that selectively bind to and activate beta-adrenergic receptors. Adrenergic beta-Receptor Agonists,beta-Adrenergic Agonists,beta-Adrenergic Receptor Agonists,Adrenergic beta-Agonist,Adrenergic beta-Receptor Agonist,Betamimetics,Receptor Agonists, beta-Adrenergic,Receptors Agonists, Adrenergic beta,beta-Adrenergic Agonist,beta-Adrenergic Receptor Agonist,Adrenergic beta Agonist,Adrenergic beta Agonists,Adrenergic beta Receptor Agonist,Adrenergic beta Receptor Agonists,Agonist, Adrenergic beta-Receptor,Agonist, beta-Adrenergic,Agonist, beta-Adrenergic Receptor,Agonists, Adrenergic beta-Receptor,Agonists, beta-Adrenergic,Agonists, beta-Adrenergic Receptor,Receptor Agonist, beta-Adrenergic,Receptor Agonists, beta Adrenergic,beta Adrenergic Agonist,beta Adrenergic Agonists,beta Adrenergic Receptor Agonist,beta Adrenergic Receptor Agonists,beta-Agonist, Adrenergic,beta-Agonists, Adrenergic,beta-Receptor Agonist, Adrenergic,beta-Receptor Agonists, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
July 1957, Acta neurologica et psychiatrica Belgica,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
January 1971, Acta paediatrica Scandinavica. Supplement,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
December 1985, Monatsschrift Kinderheilkunde : Organ der Deutschen Gesellschaft fur Kinderheilkunde,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
June 1966, Pediatriia,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
July 1991, Chest,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
March 1991, Arerugi = [Allergy],
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
December 2004, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
September 2000, Nihon rinsho. Japanese journal of clinical medicine,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
January 2012, Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury,
A Bundgaard, and T Ingemann-Hansen, and J Halkjaer-Kristensen, and A Schmidt, and I Bloch, and P K Andersen
June 2013, BMC pulmonary medicine,
Copied contents to your clipboard!